应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EBS Emergent Biosolutions
交易中 12-05 15:55:40 EST
11.88
-0.17
-1.45%
最高
12.23
最低
11.85
成交量
55.66万
今开
12.15
昨收
12.05
日振幅
3.20%
总市值
6.24亿
流通市值
6.09亿
总股本
5,252万
成交额
667.30万
换手率
1.09%
流通股本
5,126万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
芝商所部分恢复正常运作 外汇交易平台EBS市场重启
金融界 · 11-28
芝商所部分恢复正常运作 外汇交易平台EBS市场重启
芝商所 EBS 市场将于 20:00 开放
链捕手 · 11-28
芝商所 EBS 市场将于 20:00 开放
Emergent Biosolutions Inc.盘中异动 股价大跌5.16%报9.38美元
市场透视 · 11-21
Emergent Biosolutions Inc.盘中异动 股价大跌5.16%报9.38美元
Emergent BioSolutions庆祝Narcan®鼻用喷雾剂获得美国FDA批准10周年,并重申增加纳洛酮获取渠道的承诺
美股速递 · 11-18
Emergent BioSolutions庆祝Narcan®鼻用喷雾剂获得美国FDA批准10周年,并重申增加纳洛酮获取渠道的承诺
瑞立科密深交所上市:募资19亿 首日上涨50% 公司市值114亿
雷递网 · 09-30
瑞立科密深交所上市:募资19亿 首日上涨50% 公司市值114亿
Emergent Biosolutions获得1700万美元合同修订 用于天花抗病毒药物Tembexa®口服悬浮液并加强美国供应链
美股速递 · 09-15
Emergent Biosolutions获得1700万美元合同修订 用于天花抗病毒药物Tembexa®口服悬浮液并加强美国供应链
机动车主动安全系统相关核心部件厂商瑞立科密(001285.SZ)拟首次公开发行4504.45万股
智通财经 · 09-11
机动车主动安全系统相关核心部件厂商瑞立科密(001285.SZ)拟首次公开发行4504.45万股
Emergent Biosolutions获得3000万美元合同修订,用于两剂炭疽疫苗Cyfendus®(炭疽疫苗吸附佐剂型)的暴露后预防用途
美股速递 · 09-02
Emergent Biosolutions获得3000万美元合同修订,用于两剂炭疽疫苗Cyfendus®(炭疽疫苗吸附佐剂型)的暴露后预防用途
Emergent Biosolutions Inc.盘中异动 早盘快速拉升5.10%
市场透视 · 08-08
Emergent Biosolutions Inc.盘中异动 早盘快速拉升5.10%
Emergent Biosolutions Inc.盘中异动 急速拉升17.16%
市场透视 · 08-07
Emergent Biosolutions Inc.盘中异动 急速拉升17.16%
Emergent Biosolutions Inc.盘中异动 急速下跌5.08%
市场透视 · 07-31
Emergent Biosolutions Inc.盘中异动 急速下跌5.08%
Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.02%报6.81美元
市场透视 · 07-29
Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.02%报6.81美元
Emergent Biosolutions Inc.盘中异动 下午盘快速跳水5.00%
市场透视 · 07-16
Emergent Biosolutions Inc.盘中异动 下午盘快速跳水5.00%
Emergent Biosolutions Inc.盘中异动 早盘股价大涨5.17%报7.22美元
市场透视 · 07-09
Emergent Biosolutions Inc.盘中异动 早盘股价大涨5.17%报7.22美元
Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%
市场透视 · 07-08
Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%
Emergent Biosolutions Inc.盘中异动 股价大涨5.03%
市场透视 · 07-02
Emergent Biosolutions Inc.盘中异动 股价大涨5.03%
Emergent Biosolutions Inc.盘中异动 早盘快速下跌5.20%报5.47美元
市场透视 · 03-10
Emergent Biosolutions Inc.盘中异动 早盘快速下跌5.20%报5.47美元
Emergent Biosolutions Inc.股价重挫15.96% 市值跌4963.83万美元
市场透视 · 03-04
Emergent Biosolutions Inc.股价重挫15.96% 市值跌4963.83万美元
Emergent BioSolutions(EBS.US):2024年Q4财报实现营收1.947亿美元,前值为2.766亿美元,预期值为2.547亿美元;每股收益为0.05美元,前值为-0.77美元,预期值为-0.50美元。
金融界 · 03-04
Emergent BioSolutions(EBS.US):2024年Q4财报实现营收1.947亿美元,前值为2.766亿美元,预期值为2.547亿美元;每股收益为0.05美元,前值为-0.77美元,预期值为-0.50美元。
Emergent BioSolutions第四季度调整后每股收益$0.05,超出预期$(0.49),销售额$194.70M不及预期$254.67M
财报速递 · 03-04
Emergent BioSolutions第四季度调整后每股收益$0.05,超出预期$(0.49),销售额$194.70M不及预期$254.67M
加载更多
公司概况
公司名称:
Emergent Biosolutions
所属市场:
NYSE
上市日期:
--
主营业务:
Emergent Biosolutions Inc.于1998年5月在美国密歇根州成立,随后在 2004年6月改为特拉华公司。公司拥有两个经营部门:生物防卫和生物科学。该公司是一家全球性生命科学公司,专注于提供创新的准备和响应解决方案,以应对意外、故意和自然发生的公共健康威胁。
发行价格:
--
{"stockData":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent Biosolutions","latestPrice":11.875,"timestamp":1764968139053,"preClose":12.05,"halted":0,"volume":556554,"delay":0,"floatShares":51257100,"shares":52519964,"eps":1.350708,"marketStatus":"交易中","change":-0.175,"latestTime":"12-05 15:55:40 EST","open":12.15,"high":12.23,"low":11.845,"amount":6673001.203116,"amplitude":0.03195,"askPrice":11.88,"askSize":1,"bidPrice":11.87,"bidSize":81,"shortable":3,"etf":0,"ttmEps":1.350708,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1764968400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1254456000000,"exchange":"NYSE","adjPreClose":12.05,"preHourTrading":{"tag":"盘前","latestPrice":12.22,"preClose":12.05,"latestTime":"09:05 EST","volume":1182,"amount":14423.087867999999,"timestamp":1764943530220},"postHourTrading":{"tag":"盘后","latestPrice":12.1985,"preClose":12.05,"latestTime":"17:56 EST","volume":25497,"amount":307384.2194,"timestamp":1764889010684},"volumeRatio":0.746272,"impliedVol":0.6194,"impliedVolPercentile":0.312},"requestUrl":"/m/hq/s/EBS","defaultTab":"news","newsList":[{"id":"2586778235","title":"芝商所部分恢复正常运作 外汇交易平台EBS市场重启","url":"https://stock-news.laohu8.com/highlight/detail?id=2586778235","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586778235?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:27","pubTimestamp":1764332852,"startTime":"0","endTime":"0","summary":"经历数小时系统故障导致全球市场受扰后,芝商所开始逐步恢复正常运作。根据芝商所集团官网公告,外汇交易平台EBS市场已于伦敦时间中午12点重启。此次故障影响了这个全球性交易平台,追踪标普500指数、道琼斯工业平均指数和纳斯达克100指数的数百万份合约,几乎每天24小时都在芝商所进行交易。正值部分头寸仓位需要从一个月度合约延展到另一个月度合约的这个关键时刻,市场参与者损失了数小时交易时间,此次故障引发广泛不满。据设施运营商CyrusOne称,此次故障是由芝加哥地区某数据中心的冷却系统问题引发的。\n\n美股频道更多独家策划、专家专栏,免费查阅>>\n\r\n 责任编辑:山上","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"27eb7f263c6d927c789c3113b6570403","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/11/28202754472324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2586601784","title":"芝商所 EBS 市场将于 20:00 开放","url":"https://stock-news.laohu8.com/highlight/detail?id=2586601784","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586601784?lang=zh_cn&edition=full","pubTime":"2025-11-28 19:59","pubTimestamp":1764331154,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据金十报道,芝商所(CME)表示,EBS 市场将于格林威治标准时间 12:00(北京时间 20:00)开放。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2224684","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2585199088","title":"Emergent Biosolutions Inc.盘中异动 股价大跌5.16%报9.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585199088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585199088?lang=zh_cn&edition=full","pubTime":"2025-11-21 01:12","pubTimestamp":1763658766,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日01时12分,Emergent Biosolutions Inc.股票出现波动,股价急速下跌5.16%。截至发稿,该股报9.38美元/股,成交量41.0862万股,换手率0.78%,振幅8.13%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为0.40%。其相关个股中,Scilex Holding Company、Therapeuticsmd, Inc.、Scynexis, Inc.涨幅较大,Inmed Pharmaceuticals Inc.、Akanda Corp.、Hims & Hers Health, Inc.较为活跃,换手率分别为242.90%、6.61%、5.71%,振幅较大的相关个股有Therapeuticsmd, Inc.、Scilex Holding Company、Sunshine Biopharma Inc C/Wts ,振幅分别为29.70%、22.41%、21.25%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 为政府和医疗保健提供商提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121011246a4afb55f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121011246a4afb55f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"1122366777","title":"Emergent BioSolutions庆祝Narcan®鼻用喷雾剂获得美国FDA批准10周年,并重申增加纳洛酮获取渠道的承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1122366777","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122366777?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:01","pubTimestamp":1763470871,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions庆祝Narcan®鼻用喷雾剂获得美国FDA批准10周年,并重申增加纳洛酮获取渠道的承诺","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2571532268","title":"瑞立科密深交所上市:募资19亿 首日上涨50% 公司市值114亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2571532268","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571532268?lang=zh_cn&edition=full","pubTime":"2025-09-30 23:34","pubTimestamp":1759246449,"startTime":"0","endTime":"0","summary":"广州瑞立科密汽车电子股份有限公司(简称:“瑞立科密”,证券代码:001285)今日在深交所主板上市。瑞立科密发行股票4,504.4546万股,发行价为42.28元,募资19亿元。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250930/6389487198561680597949182.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250930/6389487198561680597949182.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n31350/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"1167003072","title":"Emergent Biosolutions获得1700万美元合同修订 用于天花抗病毒药物Tembexa®口服悬浮液并加强美国供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=1167003072","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167003072?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:37","pubTimestamp":1757939836,"startTime":"0","endTime":"0","summary":"Emergent Biosolutions获得1700万美元合同修订,用于口服悬浮液Tembexa®(Brincidofovir)天花抗病毒药物,并加强美国整体供应链。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2566228938","title":"机动车主动安全系统相关核心部件厂商瑞立科密(001285.SZ)拟首次公开发行4504.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566228938","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566228938?lang=zh_cn&edition=full","pubTime":"2025-09-11 06:43","pubTimestamp":1757544188,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞立科密 披露招股意向书,公司拟首次公开发行4504.4546万股,初始战略配售发行数量为450.4454万股。初步询价日期2025年9月15日,申购日期2025年9月19日。公告称,公司是专业从事机动车主动安全系统相关核心部件研发、生产和销售的国家高新技术企业,主营业务为机动车主动安全系统和铝合金精密压铸件的研发、生产和销售以及技术服务。自2022年度至2024年度,归属于母公司所有者的净利润为9696.47万元、2.36亿元、2.69亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1343882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EBS","BK4139","BK4583"],"gpt_icon":0},{"id":"1148748705","title":"Emergent Biosolutions获得3000万美元合同修订,用于两剂炭疽疫苗Cyfendus®(炭疽疫苗吸附佐剂型)的暴露后预防用途","url":"https://stock-news.laohu8.com/highlight/detail?id=1148748705","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148748705?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:40","pubTimestamp":1756813221,"startTime":"0","endTime":"0","summary":"Emergent Biosolutions获得3000万美元合同修订,用于两剂炭疽疫苗Cyfendus®(炭疽疫苗吸附佐剂型)的暴露后预防用途","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2557872578","title":"Emergent Biosolutions Inc.盘中异动 早盘快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557872578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557872578?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:40","pubTimestamp":1754660440,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时40分,Emergent Biosolutions Inc.股票出现波动,股价急速上涨5.10%。截至发稿,该股报8.66美元/股,成交量28.2647万股,换手率0.52%,振幅5.43%。Emergent Biosolutions Inc.股票所在的制药行业中,整体涨幅为1.06%。其相关个股中,Ani Pharmaceuticals, Inc.、Alpha Teknova, Inc.、Gelteq Limited涨幅较大,Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Canopy Growth Corporation较为活跃,换手率分别为82.62%、3.25%、1.40%,振幅较大的相关个股有Alpha Teknova, Inc.、Eton Pharmaceuticals, Inc.、Organogenesis Holdings Inc.,振幅分别为14.52%、13.37%、12.17%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214041973be3c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214041973be3c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4139","BK4583"],"gpt_icon":0},{"id":"2557340569","title":"Emergent Biosolutions Inc.盘中异动 急速拉升17.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557340569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557340569?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:33","pubTimestamp":1754573625,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时33分,Emergent Biosolutions Inc.股票出现异动,股价快速上涨17.16%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为3.90%。其相关个股中,Ironwood医药、Emergent Biosolutions Inc.、Avadel Pharmaceuticals Plc涨幅较大,Incannex Healthcare Inc.、Akebia Therapeutics, Inc.、大自然药业较为活跃,换手率分别为21.09%、0.75%、0.64%,振幅较大的相关个股有Avadel Pharmaceuticals Plc、Emergent Biosolutions Inc.、Akebia Therapeutics, Inc.,振幅分别为13.96%、11.19%、6.73%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213345a47b25b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213345a47b25b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2555029545","title":"Emergent Biosolutions Inc.盘中异动 急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555029545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555029545?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:02","pubTimestamp":1753898541,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时02分,Emergent Biosolutions Inc.股票出现异动,股价快速跳水5.08%。截至发稿,该股报6.17美元/股,成交量77.2007万股,换手率1.42%,振幅6.69%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为0.25%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731020221a6ca1743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731020221a6ca1743&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2555870596","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.02%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555870596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555870596?lang=zh_cn&edition=full","pubTime":"2025-07-29 01:47","pubTimestamp":1753724821,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日01时47分,Emergent Biosolutions Inc.股票出现波动,股价急速跳水5.02%。截至发稿,该股报6.81美元/股,成交量54.7037万股,换手率1.01%,振幅7.53%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为0.29%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729014701a4681f31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729014701a4681f31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2551194583","title":"Emergent Biosolutions Inc.盘中异动 下午盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194583?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:52","pubTimestamp":1752605534,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日02时52分,Emergent Biosolutions Inc.股票出现异动,股价大幅下挫5.00%。截至发稿,该股报6.94美元/股,成交量50.4952万股,换手率0.93%,振幅5.68%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为2.17%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716025214a6abb4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716025214a6abb4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"gpt_icon":0},{"id":"2550065555","title":"Emergent Biosolutions Inc.盘中异动 早盘股价大涨5.17%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550065555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550065555?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:35","pubTimestamp":1752068100,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时35分,Emergent Biosolutions Inc.股票出现异动,股价快速拉升5.17%。截至发稿,该股报7.22美元/股,成交量5.0217万股,换手率0.09%,振幅3.35%。Emergent Biosolutions Inc.股票所在的制药行业中,整体涨幅为0.96%。其相关个股中,Evoke Pharma, Inc.、Medicus Pharma Ltd.、Biofrontera Inc.涨幅较大,Evoke Pharma, Inc.、Incannex Healthcare Inc.、Medicus Pharma Ltd.较为活跃,换手率分别为2649.19%、9.45%、3.98%,振幅较大的相关个股有Evoke Pharma, Inc.、Medicus Pharma Ltd.、Tilray Brands, Inc.,振幅分别为60.89%、8.36%、6.06%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213500953c3509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213500953c3509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2549155476","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549155476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549155476?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:18","pubTimestamp":1751912329,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时18分,Emergent Biosolutions Inc.股票出现波动,股价大幅下挫5.01%。截至发稿,该股报6.64美元/股,成交量40.0435万股,换手率0.74%,振幅4.15%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为1.14%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021850a69b6c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021850a69b6c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2548688687","title":"Emergent Biosolutions Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548688687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548688687?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:11","pubTimestamp":1751386301,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时11分,Emergent Biosolutions Inc.股票出现异动,股价快速拉升5.03%。截至发稿,该股报6.70美元/股,成交量30.677万股,换手率0.57%,振幅7.60%。Emergent Biosolutions Inc.股票所在的制药行业中,整体涨幅为1.12%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001142a728c9a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001142a728c9a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2518822412","title":"Emergent Biosolutions Inc.盘中异动 早盘快速下跌5.20%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518822412","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518822412?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613729,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分,Emergent Biosolutions Inc.股票出现波动,股价大幅跳水5.20%。截至发稿,该股报5.47美元/股,成交量5.3544万股,换手率0.10%,振幅1.56%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为0.64%。其相关个股中,Sonoma Pharmaceuticals, Inc.、Alpha Teknova, Inc.、Flora Growth Corp.涨幅较大,Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃,换手率分别为52.14%、8.77%、2.85%,振幅较大的相关个股有Shuttle Pharmaceuticals Holdings, Inc.、惠普森医药、Alpha Teknova, Inc.,振幅分别为13.84%、12.67%、12.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2516677553","title":"Emergent Biosolutions Inc.股价重挫15.96% 市值跌4963.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677553","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677553?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098779,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分,Emergent Biosolutions Inc.股票出现异动,股价快速下跌15.96%。截至发稿,该股报5.74美元/股,成交量35.3898万股,换手率0.65%,振幅4.39%。Emergent Biosolutions Inc.股票所在的制药行业中,整体跌幅为0.02%。Emergent Biosolutions Inc.公司简介:Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"gpt_icon":0},{"id":"2516966912","title":"Emergent BioSolutions(EBS.US):2024年Q4财报实现营收1.947亿美元,前值为2.766亿美元,预期值为2.547亿美元;每股收益为0.05美元,前值为-0.77美元,预期值为-0.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966912","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516966912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:32","pubTimestamp":1741037576,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions(EBS.US):2024年Q4财报实现营收1.947亿美元,前值为2.766亿美元,预期值为2.547亿美元;每股收益为0.05美元,前值为-0.77美元,预期值为-0.50美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04053248499197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EBS"],"gpt_icon":0},{"id":"1101283831","title":"Emergent BioSolutions第四季度调整后每股收益$0.05,超出预期$(0.49),销售额$194.70M不及预期$254.67M","url":"https://stock-news.laohu8.com/highlight/detail?id=1101283831","media":"财报速递","labels":["merge","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101283831?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:31","pubTimestamp":1741037470,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions报告的季度每股收益为$0.05,比分析师预期的$高出110.2%。公司报告的季度销售额为$194.70M,不及分析师预期的$254.67M,低23.55%。这比去年同期的销售额$276.60M减少了29.61%。以上内容来自Benzinga Earnings专栏,原文如下:Emergent BioSolutions reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $ by 110.2 percent. This is a 106.49 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $194.70 million which missed the analyst consensus estimate of $254.67 mi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Emergent BioSolutions第四季度调整后每股收益$0.05,超出预期$(0.49),销售额$194.70M不及预期$254.67M","news_tag":"merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emergentbiosolutions.com","stockEarnings":[{"period":"1week","weight":0.0905},{"period":"1month","weight":0.1943},{"period":"3month","weight":0.5897},{"period":"6month","weight":0.8175},{"period":"1year","weight":0.2778},{"period":"ytd","weight":0.2605}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Emergent Biosolutions Inc.于1998年5月在美国密歇根州成立,随后在 2004年6月改为特拉华公司。公司拥有两个经营部门:生物防卫和生物科学。该公司是一家全球性生命科学公司,专注于提供创新的准备和响应解决方案,以应对意外、故意和自然发生的公共健康威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.736842,"avgChangeRate":0.048562},{"month":2,"riseRate":0.421053,"avgChangeRate":-0.000132},{"month":3,"riseRate":0.421053,"avgChangeRate":-0.035402},{"month":4,"riseRate":0.473684,"avgChangeRate":-0.035609},{"month":5,"riseRate":0.578947,"avgChangeRate":0.111206},{"month":6,"riseRate":0.631579,"avgChangeRate":0.011895},{"month":7,"riseRate":0.578947,"avgChangeRate":0.106316},{"month":8,"riseRate":0.473684,"avgChangeRate":-0.017792},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.034511},{"month":10,"riseRate":0.578947,"avgChangeRate":0.029583},{"month":11,"riseRate":0.578947,"avgChangeRate":-0.002144},{"month":12,"riseRate":0.6,"avgChangeRate":0.042712}],"exchange":"NYSE","name":"Emergent Biosolutions","nameEN":"Emergent BioSolutions"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Emergent Biosolutions,EBS,Emergent Biosolutions股票,Emergent Biosolutions股票老虎,Emergent Biosolutions股票老虎国际,Emergent Biosolutions行情,Emergent Biosolutions股票行情,Emergent Biosolutions股价,Emergent Biosolutions股市,Emergent Biosolutions股票价格,Emergent Biosolutions股票交易,Emergent Biosolutions股票购买,Emergent Biosolutions股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}